DUBLIN, Sept. 3, 2019 /PRNewswire/ — Allergan plc (NYSE: AGN) announced today it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm Voluma XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE™…Original Article
FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannula
